What is Imdur (isosorbide mononitrate) used for?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Imdur Used For?

Imdur (isosorbide mononitrate extended-release) is primarily indicated for the prevention of angina pectoris due to coronary artery disease. 1

Primary Indication: Angina Prevention

  • Imdur is FDA-approved specifically for preventing anginal episodes in patients with chronic stable angina caused by coronary artery disease. 1
  • The medication works by dilating coronary arteries (both normal and atherosclerotic), enhancing collateral blood flow, and redistributing coronary blood flow to ischemic regions. 2
  • It is NOT effective for aborting acute anginal attacks due to insufficient rapidity of onset—patients need sublingual nitroglycerin for acute episodes. 1

Dosing and Administration

  • The most commonly studied and effective dose is 60 mg once daily, which provides antianginal protection for approximately 1 to 12 hours after administration. 3, 4
  • Once-daily morning administration provides effective prophylaxis throughout the day while allowing a nitrate-free interval overnight to prevent tolerance. 3, 4
  • Higher doses (120-240 mg daily) may be used for more severe symptoms, with evidence showing maintained efficacy at 6 weeks compared to lower doses. 3

Combination Therapy

  • Imdur is particularly effective when added to beta-blocker therapy, significantly increasing exercise capacity and reducing anginal attacks beyond beta-blockade alone. 5
  • The combination of isosorbide mononitrate with beta-blockers provides superior antianginal protection compared to either agent alone. 5

Secondary Use: Heart Failure (Specific Populations)

While not the primary FDA indication for Imdur specifically, isosorbide mononitrate (as part of the broader nitrate class) has an important role in heart failure:

  • In African American patients with NYHA class III-IV heart failure with reduced ejection fraction, the combination of hydralazine plus isosorbide dinitrate (which includes mononitrate formulations) reduces mortality. 6, 2
  • This combination should be added to standard heart failure therapy (ACE inhibitors/ARBs, beta-blockers, mineralocorticoid receptor antagonists) in symptomatic African American patients. 6
  • The benefit is presumed related to enhanced nitric oxide bioavailability. 6, 2
  • For patients intolerant of ACE inhibitors or ARBs (due to hypotension or renal insufficiency), the hydralazine-nitrate combination may be considered, though evidence is limited in this population. 6

Important Safety Considerations

Absolute Contraindications

  • Never use with phosphodiesterase-5 inhibitors (sildenafil, tadalafil, vardenafil) due to risk of profound hypotension, myocardial infarction, and death. 6, 2
  • Avoid in patients with systolic blood pressure <90 mmHg or >30 mmHg below baseline. 6, 2

Use With Caution

  • Patients with aortic stenosis may experience marked hypotension following nitrate administration. 2
  • Headache is the most common side effect but typically resolves within 5-6 days and rarely requires discontinuation. 3, 7

Tolerance Prevention

  • A nitrate-free interval of at least 10 hours is essential to prevent tolerance. 6, 2
  • Once-daily Imdur administration naturally provides this interval overnight, maintaining efficacy during long-term treatment. 3, 4
  • Studies show no evidence of classical tolerance with once-daily Imdur 60 mg over extended periods when the nitrate-free interval is maintained. 3, 4

Withdrawal Considerations

  • Abrupt discontinuation after long-term treatment may exacerbate anginal symptoms in some patients, though rebound ischemia is not consistently observed. 3, 8
  • If discontinuation is necessary, consider gradual tapering rather than abrupt cessation. 8

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.